Vanguard Group’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,794,761
| Closed | -$17.8M | – | 4632 |
|
|
2023
Q1 | $17.8M | Buy |
1,794,761
+327,394
| +22% | +$3.24M | ﹤0.01% | 2639 |
|
|
2022
Q4 | $14.6M | Buy |
1,467,367
+105,589
| +8% | +$787K | ﹤0.01% | 2782 |
|
|
2022
Q3 | $7.5M | Buy |
1,361,778
+15,400
| +1% | +$85.4K | ﹤0.01% | 3096 |
|
|
2022
Q2 | $4.91M | Hold |
1,346,378
| – | – | ﹤0.01% | 3381 |
|
|
2022
Q1 | $8.14M | Buy |
1,346,378
+53,261
| +4% | +$325K | ﹤0.01% | 3260 |
|
|
2021
Q4 | $10.9M | Buy |
1,293,117
+519,810
| +67% | +$4.54M | ﹤0.01% | 3161 |
|
|
2021
Q3 | $7.01M | Buy |
773,307
+105,595
| +16% | +$908K | ﹤0.01% | 3454 |
|
|
2021
Q2 | $5.41M | Buy |
667,712
+129,704
| +24% | +$890K | ﹤0.01% | 3552 |
|
|
2021
Q1 | $2.96M | Buy |
538,008
+27,368
| +5% | +$135K | ﹤0.01% | 3763 |
|
|
2020
Q4 | $1.74M | Sell |
510,640
-63
| -0% | -$166 | ﹤0.01% | 3702 |
|
|
2020
Q3 | $862K | Sell |
510,703
-707
| -0.1% | -$1.07K | ﹤0.01% | 3690 |
|
|
2020
Q2 | $836K | Hold |
511,410
| – | – | ﹤0.01% | 3649 |
|
|
2020
Q1 | $982K | Hold |
511,410
| – | – | ﹤0.01% | 3497 |
|
|
2019
Q4 | $1.46M | Hold |
511,410
| – | – | ﹤0.01% | 3533 |
|
|
2019
Q3 | $1.7M | Buy |
511,410
+100,083
| +24% | +$317K | ﹤0.01% | 3501 |
|
|
2019
Q2 | $1.34M | Buy |
411,327
+155,263
| +61% | +$552K | ﹤0.01% | 3586 |
|
|
2019
Q1 | $958K | Buy |
256,064
+83,541
| +48% | +$292K | ﹤0.01% | 3634 |
|
|
2018
Q4 | $595K | Sell |
172,523
-297,624
| -63% | -$1.47M | ﹤0.01% | 3701 |
|
|
2018
Q3 | $3.37M | Buy |
470,147
+300,012
| +176% | +$2.33M | ﹤0.01% | 3364 |
|
|
2018
Q2 | $1.19M | Buy |
170,135
+35,021
| +26% | +$218K | ﹤0.01% | 3642 |
|
|
2018
Q1 | $831K | Buy |
135,114
+94,131
| +230% | +$593K | ﹤0.01% | 3689 |
|
|
2017
Q4 | $229K | Buy |
+40,983
| New | +$187K | ﹤0.01% | 3908 |
|
|
2016
Q4 | – | Sell |
-2,201
| Closed | -$39K | – | 4089 |
|
|
2016
Q3 | $39K | Buy |
+2,201
| New | +$29.3K | ﹤0.01% | 4048 |
|
|
2016
Q2 | – | Sell |
-792
| Closed | -$11K | – | 4145 |
|
|
2016
Q1 | $11K | Hold |
792
| – | – | ﹤0.01% | 4129 |
|
|
2015
Q4 | $13K | Hold |
792
| – | – | ﹤0.01% | 4181 |
|
|
2015
Q3 | $12K | Buy |
792
+134
| +20% | +$2.55K | ﹤0.01% | 4184 |
|
|
2015
Q2 | $14K | Sell |
658
-1,234
| -65% | -$122K | ﹤0.01% | 4185 |
|
|
2015
Q1 | $360K | Buy |
1,892
+42
| +2% | +$9.65K | ﹤0.01% | 3903 |
|
|
2014
Q4 | $402K | Buy |
1,850
+21
| +1% | +$4.69K | ﹤0.01% | 3788 |
|
|
2014
Q3 | $496K | Buy |
1,829
+65
| +4% | +$17.7K | ﹤0.01% | 3712 |
|
|
2014
Q2 | $539K | Hold |
1,764
| – | – | ﹤0.01% | 3661 |
|
|
2014
Q1 | $647K | Buy |
1,764
+296
| +20% | +$107K | ﹤0.01% | 3584 |
|
|
2013
Q4 | $481K | Buy |
1,468
+260
| +22% | +$95.5K | ﹤0.01% | 3605 |
|
|
2013
Q3 | $519K | Buy |
1,208
+702
| +139% | +$307K | ﹤0.01% | 3542 |
|
|
2013
Q2 | $171K | Buy |
+506
| New | +$190K | ﹤0.01% | 3662 |
|
Vanguard Group's APEN Position: Q2 2023 in Review
Vanguard Group sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 1,794,761 shares — an estimated $17.8M sold.
Vanguard Group first reported a position in APEN in Q2 2013 and held it in 35 quarters. The position peaked at $17.8M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Vanguard Group reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Vanguard Group sold 1,794,761 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $17.8M.
- Vanguard Group first reported a position in Apollo Endosurgery, Inc. in Q2 2013 and held it in 35 quarters.
- Vanguard Group's Apollo Endosurgery, Inc. position peaked at $17.8M in Q1 2023.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Vanguard Group's 13F filing for Q2 2023, filed 14 Aug 2023.